Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

Bibliography

• SONDIK EJ: Breast cancer trends. Incidence, mortality,and survival. Cancer (1994) 74:995–999.
   Google Scholar
• CHU KC, TARONE RE, KESSLER LG et al.: Recent trends inUS breast cancer incidence, survival, and mortality rates. J. Natl Cancer Inst. (1996) 88:1571–1579.
   PubMed Web of Science ®Google Scholar
• PARKIN DM, MUIR CS, WHELAN SL et al: Cancer Incidence in Five Continents. (1992) IARC Sci. Publ. 120.
   Google Scholar
• HULKA BS, LIU ET, LININGER RA: Steroid hormones and risk of breast cancer. Cancer (1994) 74:1111–1124.
   PubMed Web of Science ®Google Scholar
• MACGREGOR JI, JORDAN VC: Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. (1998) 50:151–196.
   PubMed Web of Science ®Google Scholar
• GRADISHAR WJ, JORDAN VC: Clinical potential of new antiestrogens. j Clin. Oncol. (1997) 15:840–852.
   PubMed Web of Science ®Google Scholar
• JOHNSTON SR: Acquired tamoxifen resistance in human breast cancer-potential mechanisms and clinical implications. AntiCancer Drugs (1997) 8:911–930.
   PubMed Web of Science ®Google Scholar
• RUSSO J, RUSSO IH: Experimentally induced mammary tumors in rats. Breast Cancer Res. Treat. (1996) 39:7–20.
   PubMed Web of Science ®Google Scholar
• RUSSO J, RUSSO IH: Biological and molecular bases of mammary carcinogenesis. Lab. Invest. (1987) 57:112–137.
   PubMed Web of Science ®Google Scholar
• POLAND A, GLOVER E, KENDE AS: Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. (1976) 251:4936–4946.
   PubMed Web of Science ®Google Scholar
• SAFE S: Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther. (1995) 67:247–281.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN JA, SAFE S: Mechanism of action and structure-activity relationships for the chlorinated dibenzo-p-dioxins and related compounds. In: Halogenated Biphenyls, Naphthalenes, Dibenzodioxins and Related Compounds. Kimbrough RD, Jensen AA (Eds.), Elsevier-North Holland, Amsterdam (1989):239–293.
   Google Scholar
• POLAND A, KNUTSON JC: 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. (1982) 22:517–554.
   PubMed Web of Science ®Google Scholar
• SAFE S: Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Ann. Rev. Pharmacol Toxicol. (1986) 26:371–399.
   PubMed Web of Science ®Google Scholar
• KOCIBA RJ, KEYES DG, BEGER JE et al.: Results of a2-year chronic toxicity and oncogenicity study of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol Appl. Pharmacol. (1978) 46:279–303.
   PubMed Web of Science ®Google Scholar
• WHITLOCK JP, JR.: Mechanistic aspects of dioxin action. Chem. Res. Toxicol. (1993) 6:754–763.
   PubMed Web of Science ®Google Scholar
• WHITLOCK JP, OKINO ST, DONG L et al.: Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. (1996) 10:809–818.
   PubMed Web of Science ®Google Scholar
• •Molecular mechanism of AhR action - review.
   Google Scholar
• WILSON CL, SAFES: Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicologic Pathol. (1998) 26:657–671.
   PubMed Web of Science ®Google Scholar
• •Molecular mechanism of AhR action - review.
   Google Scholar
• SWANSON HI, BRADFIELD CA: The Ah-receptor: genetics, structure and function. Pharmacogenetics (1993) 3:213–223.
   PubMedGoogle Scholar
• EMA M, SOGAWA K, WATANABE N et al: cDNA cloning and structure of the putative Ah receptor. Biochem. Biophys. Res. Comm. (1992) 184:246–253.
   PubMed Web of Science ®Google Scholar
• EMA M, OHE N, SUZUKI M et al: Dioxin binding activi-ties of polymorphic forms of mouse and human aryl hydrocarbon receptors. J. Biol. Chem. (1994) 269:27337–27343.
   PubMed Web of Science ®Google Scholar
• DOLWICK KM, SCHMIDT JV, CARVER LA, SWANSON HI, BRADFIELD CA: Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. (1993) 44:911–917.
   PubMed Web of Science ®Google Scholar
• SCHMIDT JV, CARVER LA, BRADFIELD CA: Molecular characterization of the murine Ahr gene: organiza-tion, promoter analysis, and chromosomal assign-ment. J. Biol. Chem. (1993) 268:22203–22209.
   PubMed Web of Science ®Google Scholar
• BURBACH KM, POLAND AB, BRADFIELD CA: Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. ScL USA (1992) 89:8185–8189.
   PubMed Web of Science ®Google Scholar
• HOFFMAN EC, REYES H, CHU F-F et al.: Cloning of a factor required for activity of the Ah (dioxin) receptor. Science (1991) 252:954–958.
   PubMed Web of Science ®Google Scholar
• BEATO M, HERRLICH P, SCHUTZ G: Steroid hormonereceptors: many actors in search of a plot. Cell (1995) 83:851–857.
   PubMed Web of Science ®Google Scholar
• KASTNER P, MARK M, CHAMBON P: Nonsteroid nuclearreceptors: what are genetic studies telling us about their role in real life? Cell (1995) 83:859–869.
   PubMed Web of Science ®Google Scholar
• MANGELSDORF DJ, THUMMEL C, BEATO M et al.: The nuclear receptor superfamily: the second decade. Cell (1995) 83:835–839.
   PubMed Web of Science ®Google Scholar
• PERLMANN T, EVANS RM: Nuclear receptors in Sicily: all in the famiglia. Cancer Res. Cell (1997) 90:391–397.
   Google Scholar
• RESCHE-RIGON M, GRONEMEYER H: Therapeutic potential of selective modulators of nuclear receptor action. Curr. Opin. Chem. Biol. (1998) 2:501–507.
   PubMed Web of Science ®Google Scholar
• KLIEWER SA, LEHMANN JM, WILLSON TM: Orphan nuclear receptors: shifting endocrinology into reverse. Science (1999) 284:757–760.
   PubMed Web of Science ®Google Scholar
• HERBST AL, BERN HA: Thieme-Stratton, New York (1981):
   Google Scholar
• NEWBOLD R: Cellular and molecular effects of develop-mental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ. Health Perspect. (1995) 103:83–87.
   PubMed Web of Science ®Google Scholar
• GUSTAFSSON JA: Therapeutic potential of selective estrogen receptor modulators. Curr. Opin. Chem. Biol. (1998) 2:508–511.
   PubMedGoogle Scholar
• LAKE BG: Role of oxidative stress and enhanced cellreplication in the hepatocarcinogenicity of peroxi-some proliferators. In: Peroxisomes: Biology, and Importance in Toxicology and Medicine. Gibson G, Lake B (Eds.), Taylor and Francis, Washington, D.C. (1993):595–618.
   Google Scholar
• ABBOTT BD, HARRIS MW, BIRNBAUM LS: Etiology of retinoic acid-induced cleft palate varies with the embryonic stage. Teratology (1989) 40:533–553.
   PubMedGoogle Scholar
• HOLCOMB M, SAFE S: Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Letters (1994) 82:43–47.
   PubMed Web of Science ®Google Scholar
• TRITSCHER AM, CLARK GC, SEWALL C et al.: Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Carcinogenesis (1995) 16:2807–2811.
   PubMed Web of Science ®Google Scholar
• GIERTHY JF, BENNETT JA, BRADLEY LM, CUTLER DS: Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. (1993) 53:3149–3153.
   PubMed Web of Science ®Google Scholar
• UMBREIT TH, GALLO MA: Physiological implications ofestrogen receptor modulation by 2,3,7,8-tetrachlorodi benzo-p-dioxin. Toxicol Lett. (1988) 42:5–14.
   PubMed Web of Science ®Google Scholar
• UMBREIT TH, HESSE EJ, MACDONALD GJ, GALLO MA: Effects of TCDD-estradiol interactions in three strains of mice. Toxicol. Lett. (1988) 40:1–9.
   PubMed Web of Science ®Google Scholar
• UMBREIT TH, SCALA PL, MACKENZIE SA, GALLO MA: Alteration of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) by estradiol and tamoxifen. Toxicology (1989) 59:163–169.
   PubMed Web of Science ®Google Scholar
• ROMKES M, SAFE S: Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and proges-terone on antiestrogens in the female rat uterus. Toxicol Appl. Pharmacol (1988) 92:368–380.
   PubMed Web of Science ®Google Scholar
• ROMKES M, PISKORSKA-PLISZCZYNSKA J, SAFES: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol. Appl. Pharmacol. (1987) 87:306–314.
   PubMed Web of Science ®Google Scholar
• ASTROFF B, SAFE S: Comparative antiestrogenic activi-ties of 2,3,7,8- tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8- trichlorodibenzofuran in the female rat. Toxicol Appl. Pharmacol (1988) 95:435–443.
   PubMed Web of Science ®Google Scholar
• ASTROFF B, ROWLANDS C, DICKERSON R, SAFE S: 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17?-estradiol-induced increases in rat uterine EGF receptor binding activity and gene expression. Mol. Endocrinol. (1990) 72:247–252.
   Web of Science ®Google Scholar
• ASTROFF B, ELDRIDGE B, SAFE S: Inhibition of 17?-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8- tetrachlo-rodibenzo-p-dioxin (TCDD) in the female uterus. Toxicol Lett. (1991) 56:305–315.
   PubMed Web of Science ®Google Scholar
• GIERTHY JF, LINCOLN DW, GILLESPIE MB et al.: Suppres-sion of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetra chloro-dibenzo- p-dioxin. Cancer Res. (1987) 47:6198–6203.
   PubMed Web of Science ®Google Scholar
• GIERTHY JF, LINCOLN DW: Inhibition of postconfluent focus production in cultures of MCF- 7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res. (1988) 12:227–233.
   Web of Science ®Google Scholar
• BIEGEL L, SAFE S: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160- kDa proteins in human breast cancer cells. J. Steroid Biochem. Mol. Biol. (1990) 37:725–732.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ P, SAFES: Growth inhibitory and antimito-genic activity of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicol. Lett. (1992) 61:185–197.
   PubMed Web of Science ®Google Scholar
• LIU H, BIEGEL L, NARASIMHAN TR, ROWLANDS C, SAFES:Inhibition of insulin-like growth factor-I responses in MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Mol Cell. Endocrinol. (1992) 87:19–28.
   PubMed Web of Science ®Google Scholar
• LIU H, SAFE S: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on insulin-induced responses in MCF-7 human breast cancer cells. Toxicol Appl. Pharmacol. (1996) 138:242–250.
   PubMed Web of Science ®Google Scholar
• VICKERS PJ, DUFRESNE MJ, COWAN KH: Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells. Mol. Endocrinol (1989) 3:157–164.
   PubMed Web of Science ®Google Scholar
• HARRIS M, PISKORSKA-PLISZCZYNSKA J, ZACHAREWSKIT, ROMKES M, SAFES: Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Cancer Res. (1989) 49:4531–4535.
   PubMed Web of Science ®Google Scholar
• WANG X, THOMSEN JS, SANTOSTEFANO M et al.: Comparative properties of the nuclear Ah receptor complex from several human cell lines. Eur. J. Pharmacol. (1995) 293:191–205.
   PubMed Web of Science ®Google Scholar
• WANG W, PORTER W, BURGHARDT R, SAFE S: Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodi benzo-p-dioxin. Carcinogenesis (1997) 18:925–933.
   PubMed Web of Science ®Google Scholar
• KRISHNAN V, SAFE S: Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofu-rans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relation-ships. Toxicol Appl. Pharmacol (1993) 120:55–61.
   PubMed Web of Science ®Google Scholar
• KRISHNAN V, NARASIMHAN TR, SAFE S: Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells. Anal. Biochem. (1992) 204:137–142.
   PubMed Web of Science ®Google Scholar
• KRISHNAN V, PORTER W, SANTOSTEFANO M, WANG X,SAFE S: Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol Cell. Biol. (1995) 15:6710–6719.
   PubMed Web of Science ®Google Scholar
• NARASIMHAN TR, SAFE S, WILLIAMS HJ, SCOTT Al:Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17?-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C-nuclear magnetic resonance studies. Mol. Pharmacol (1991) 40:1029–1035.
   PubMed Web of Science ®Google Scholar
• HARPER N, WANG X, LIU H, SAFE S: Inhibition ofestrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol (1994) 104:47–55.
   PubMed Web of Science ®Google Scholar
• ZACHAREWSKI TR, BONDY KL, MCDONELL P, WU ZF: Antiestrogenic effects of 2,3,7,8-tetrachlorodi benzo-p-dioxin on 17?-estradiol-induced pS2 expres-sion. Cancer Res. (1994) 54:2707–2713.
   PubMed Web of Science ®Google Scholar
• LUY-F, SUN G, WANG X, SAFE S: Inhibition of prolactinreceptor gene expression by 2,3,7,8-tetrachlorodi benzo-p-dioxin in MCF-7 human breast cancer cells. Arch. Biochem. Biophys. (1996) 332:35–40.
   PubMed Web of Science ®Google Scholar
• GILLESBY B, SANTOSTEFANO M, PORTER W et al.: Identi-fication of a motif within the 5'-regulatory region on p52 which is responsible for Apl binding and TCDD-mediated suppression. Biochemistry (1997) 36:6080–6089.
   PubMed Web of Science ®Google Scholar
• NODLAND KI, WORMKE M, SAFE S: Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodi benzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitello-genin A2 gene promoter constructs. Arch. Biochem. Biophys. (1997) 338:67–72.
   PubMed Web of Science ®Google Scholar
• WANG W, SMITH R, SAFES: Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes. Arch. Biochem. Biophys. (1998) 356:239–248.
   PubMed Web of Science ®Google Scholar
• RAMAMOORTHY K, GUPTA MS, SUN G, MCDOUGAL A, SAFE SH 3,3',4,4'-Tetrachlorobiphenyl exhibits anties-trogenic and antitumorigenic activity in the rodent uterus and mammary and in human breast cancer cells. Carcinogenesis (1999) 20:115–123.
   PubMed Web of Science ®Google Scholar
• DUAN R, PORTER W, SAMUDIO I et al: Transcriptional activation of c-fos protooncogene by 176-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Endocrinol. (1999) In Press.
   Google Scholar
• SAFE S: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related environmental antiestrogens: characteri-zation and mechanism of action. In: Endocrine Disrup-tors. Naz RK (Ed.), CRC Press, Boca Raton, FL (1999):187–221.
   Google Scholar
• ••AhR-mediated inhibition of oestrogen-induced responses -review.
   Google Scholar
• MOORE M, WANG X, LU Y-F et al.: Benzo[a]pyrene resistant (BaPR) human breast cancer cells: a unique aryl hydrocarbon (Ah)-nonresponsive clone. J. Biol. Chem. (1994) 269:11751–11759.
   PubMed Web of Science ®Google Scholar
• HARRIS M, ZACHAREWSKI T, SAFE S: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells. Cancer Res. (1990) 50:3579–3584.
   PubMed Web of Science ®Google Scholar
• SPINK DC, LINCOLN DW, DICKERMAN HW, GIERTHY JF: 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 176-estradiol metabolism in human breast cancer cells. Proc. Natl. Acad. Sci. USA (1990) 87:6917–6921.
   PubMed Web of Science ®Google Scholar
• SPINK DC, EUGSTER H-P, LINCOLN DW, II et al: 1713-Estradiol hydroxylation catalyzed by human cytochrome P4501A1: a comparison of the activities induced by 2,3,7,8- tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys. (1992) 293:342–348.
   PubMed Web of Science ®Google Scholar
• SPINK DC, JOHNSON JA, CONNOR SP, ALDOUS KM, GIERTHY JF: Stimulation of 17?-estradiol metabolism in MCF-7 cells by bromochloro- and chloromethyl-substituted dibenzo-p-dioxins and dibenzofurans: correlations with antiestrogenic activity. J. Toxicol. Environ. Health (1994) 41:451–466.
   PubMed Web of Science ®Google Scholar
• HAYES CL, SPINK DC, SPINK BC et al.: 176-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA (1996) 93:9776–9781.
   PubMed Web of Science ®Google Scholar
• DENISON MS, PHELAN D, ELFERINK CJ: The Ah receptor signal transduction pathway. In: Toxicant-Receptor Interactions. Denison MS, Helferich WG (Eds.), Taylor and Francis, Philadelphia (1998)3–33.
   Google Scholar
• SWANSON HI, CHAN WK, BRADFIELD CA: DNA binding specificities and pairing rules of the Ah receptor, ARNT, and KM proteins. J. Biol. Chem. (1995) 270:26292–26302.
   PubMed Web of Science ®Google Scholar
• PARKINSON A, THOMAS PE, RYAN DE et al: Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorodibiphenyls. Toxicology (1988) 53:289–300.
   PubMed Web of Science ®Google Scholar
• ASTROFF B, ZACHAREWSKI T, SAFE S et al.: 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. Mol. Pharmacol. (1988) 33:231–236.
   PubMed Web of Science ®Google Scholar
• HARRIS M, ZACHAREWSKI T, ASTROFF B, SAFE S: Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p -dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Mol. Pharmacol. (1989) 35:729–735.
   PubMed Web of Science ®Google Scholar
• PISKORSKA-PLISZCZYNSKA J, ASTROFF B, ZACHAREWSKI T et al.: Mechanism of action of 2, 3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes. Arch. Biochem. Biophys. (1991) 284:193–200.
   PubMed Web of Science ®Google Scholar
• ASTROFF B, SAFE S: 6-Substituted-1,3,8-trichloro dibenzofurans as 2,3,7,8- tetrachlorodibenzo-p-dioxin antagonists in the rat: structure- activity relationships. Toxicology (1989) 59:285–296.
   PubMed Web of Science ®Google Scholar
• BANNISTER R, BIEGEL L, DAVIS D, ASTROFF B, SAFE S: 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8- tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice. Toxicology (1989) 54:139–150.
   PubMed Web of Science ®Google Scholar
• YAO C, SAFE S: 2,3,7,8-Tetrachlorodibenzo-p-dioxin--induced porphyria in genetically inbred mice: partial antagonism and mechanistic studies. Toxicol. Appl. Pharmacol. (1989) 100:208–216.
   PubMed Web of Science ®Google Scholar
• SANTOSTEFANO M, SAFE S: Characterization of the molecular and structural properties of the transformed and nuclear aryl hydrocarbon (Ah) receptor complexes by proteolytic digestion. Chem. Biol. Interact. (1996) 100:221–240.
   PubMed Web of Science ®Google Scholar
• SAFE S: MCDF, 6-methyl-1,3,8-trichlorodibenzofuran. Drugs of the Future (1992) 17:564–565.
   Google Scholar
• ASTROFF B, SAFE S: 6-Alkyl-1,3,8-trichlorodi benzofu-rans as antiestrogens in female Sprague-Dawley rats. Toxicology (1991) 69:187–197.
   PubMed Web of Science ®Google Scholar
• ZACHAREWSKI T, HARRIS M, BIEGEL L et al.: 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor. Toxicol Appl. Pharmacol. (1992) 13:311–318.
   Web of Science ®Google Scholar
• SUN G, SAFE S: Antiestrogenic activities of alternate substituted polychlorinated dibenzofurans in MCF-7 human breast cancer cells. Cancer Chemother. Pharmacol. (1997) 40:239–244.
   PubMed Web of Science ®Google Scholar
• DICKERSON R, HOWIE-KELLER L, SAFE S: Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies. Toxicol. Appl. Pharmacol. (1995) 135:287–298.
   PubMed Web of Science ®Google Scholar
• MCDOUGAL A, WILSON C, SAFE S: Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Lett. (1997) 120:53–63.
   PubMed Web of Science ®Google Scholar
• ••Antitumourigenic activity of SAhRMs.
   Google Scholar
• BJELDANES LF, KIM JY, GROSE KR, BARTHOLOMEW JC, BRADFIELD CA: Aromatic hydrocarbonresponsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo - comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA (1991) 88:9543–9547.
   PubMed Web of Science ®Google Scholar
• JELLINCK PH, FORKERT PG, RIDDICK DS et al.: Ahreceptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol. (1993) 43:1129–1136.
   Web of Science ®Google Scholar
• GILLNER M, BERGMAN J, CAMBILLAU C et al: Interac-tions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. (1993) 44:336–345.
   PubMed Web of Science ®Google Scholar
• LIU RM, VASILIOU V, ZHU H et al.: Regulation of [Agene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines. Carcinogenesis (1994) 15:2347–2352.
   PubMed Web of Science ®Google Scholar
• GILLNER M, BERGMAN J, CAMBILLAU C, GUSTAFSSON J:Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis (1989) 10:651–654.
   PubMed Web of Science ®Google Scholar
• NAIR RV, FISHER EP, SAFE S et al. : Novel coumarins aspotential anticarcinogenic agents. Carcinogenesis (1991) 12:65–70.
   PubMed Web of Science ®Google Scholar
• CIOLINO HP, WANG TT, YEH GC: Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. (1998) 58:2754–2760.
   PubMed Web of Science ®Google Scholar
• PHELAN D, WINTER GM, ROGERS WJ, LAM JC, DENISON MS: Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys. (1998) 357:155–163.
   PubMed Web of Science ®Google Scholar
• SINAL CJ, BEND JR: Aryl hydrocarbon receptor-dependent induction of cyplal by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol. Pharmacol. (1997) 52:590–599.
   PubMed Web of Science ®Google Scholar
• GRADELET S, ASTORG P, PINEAU T et al.: Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and 8-apo-8'-carotenal, with no affinity for the TCDD binding site. Biochem. Pharmacol. (1997) 54:307–315.
   PubMed Web of Science ®Google Scholar
• CHEN I, SAFE S, BJELDANES L: Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol (1996) 51:1069–1076.
   PubMed Web of Science ®Google Scholar
• CHEN I, MCDOUGAL A, WANG F, SAFE S: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis (1998) 19:1631–1639.
   PubMed Web of Science ®Google Scholar
• ••Antitumourigenic activity of SAhRMs.
   Google Scholar
• WATTENBERG LW, LOUB WD: Inhibition of aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. (1978) 38:1410–1413.
   PubMed Web of Science ®Google Scholar
• STOEWSAND GS, ANDERSON JL, MUNSON L: Protective effect of dietary brussels sprouts against mammary carcinogenesis in Sprague-Dawley rats. Cancer Lett. (1988) 39:199–207.
   PubMed Web of Science ®Google Scholar
• KIM DJ, LEE KK, HAN BS et al.: Biphasic modifying effect on indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res. (1994) 85:578–583.
   PubMedGoogle Scholar
• MORSE MA, LAGRECA SD, AMIN SG, CHUNG FL: Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitro-samino)-1-(3-pyric10-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res. (1990) 50:1613–1617.
   PubMedGoogle Scholar
• TANAKA T, KOJIMA T, MORISHITA Y, MORI H: Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcino-genesis. Jpn. J. Cancer Res. (1992) 83:835–842.
   PubMedGoogle Scholar
• TANAKA T, MORI Y, MORISHITA Y et al.: Inhibitory effect of sinigrin and indole-3-carbinol in diethylnitrosamine-induced hepatocarcinogenesis in male ACl/N rats. Carcinogenesis (1990) 11:1403–1406.
   PubMed Web of Science ®Google Scholar
• GRUBBS CJ, STEELE VE, CASEBOLT T et al: Chemopre-vention of chemically-induced mammary carcino-genesis by indole-3-carbinol. AntiCancer Res. (1995) 15:709–716.
   PubMed Web of Science ®Google Scholar
• BRADLOW HL, MICHNOVICZ JJ, TELANG NT, OSBORNE MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis (1991) 12:1571–1574.
   PubMed Web of Science ®Google Scholar
• KOJIMA T, TANAKA T, MORI H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indo1-3-carbinol. Cancer Res. (1994) 54:1446–1449.
   PubMed Web of Science ®Google Scholar
• DE KRUIF CA, MARSMAN JW, VENEKAMP JC et al.: Structure elucidation of acid reaction products of indole-3- carbinol: detection in vivo and enzyme induction in vitro. Chem. Biol. Interact. (1991) 80:303–315.
   PubMed Web of Science ®Google Scholar
• GROSE KR, BJELDANES LF: Oligomerization of indole-3-carbinol in aqueous acid. Chem. Res. Toxicol (1992) 5:188–193.
   PubMed Web of Science ®Google Scholar